Severe acute pancreatitis is related to increased early urinary levels of the activation Peptide of pancreatic phospholipase A(2).

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12435866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk

  2002cited by this paper
• Levels of the chemokines growth‐related oncogene α and epithelial neutrophil‐activating protein 78 are raised in patients with severe acute pancreatitis

  2002cited by this paper
• MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation.

  2002cited by this paper
• Serum amyloid A is a better early predictor of severity than C‐reactive protein in acute pancreatitis

  2002cited by this paper
• Plasma type II phospholipase A2 levels in patients with acute pancreatitis.

  2001cited by this paper
• Expression of Group II Phospholipase A2 in the Liver in Acute Pancreatitis

  2001cited by this paper
• Phospholipase A2 Isoforms in Acute Pancreatitis

  2001cited by this paper
• Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury

  2000cited by this paper
• SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.

  2000cited by this paper
• Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells.

  2000cited by this paper
• Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study.

  2000cited by this paper
• Local and Systemic Zymogen Activation in Human Acute Pancreatitis

  2000cited by this paper
• Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.

  2000cited by this paper
• Mechanisms of intracellular zymogen activation.

  1999cited by this paper
• Cytokines and acute pancreatitis.

  1999cited by this paper
• Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis.

  1999cited by this paper
• A prospective study of serum pancreatic elastase-1 in the diagnosis and assessment of acute pancreatitis.

  1998cited by this paper
• Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis

  1998cited by this paper
• Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis.

  1998cited by this paper
• Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury.

  1998cited by this paper
• Studies on the Turnover of Procarboxypeptidase B, Its Active Enzyme and the Activation Peptide in the Pig

  1998cited by this paper
• Secretory Phospholipase A2 in Patients with Infected Pancreatic Necroses in Acute Pancreatitis

  1998cited by this paper
• Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis

  1997cited by this paper
• Pathophysiological role of secretory type I and II phospholipase A2 in acute pancreatitis: an experimental study in rats.

  1997cited by this paper
• Increased serum trypsinogen 2 and trypsin 2-α1antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy

  1997cited by this paper
• Serum phospholipase A2, amylase, lipase, and urinary amylase activities in relation to the severity of acute pancreatitis.

  1997cited by this paper
• Serum complex of trypsin 2 and (alpha)(sub 1) antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients

  1996cited by this paper
• Type 1-prophospholipase A2 propeptide immunoreactivity is released from activated granulocytes.

  1995cited by this paper
• Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats.

  1995cited by this paper
• The Relationship Between Pancreatic Enzyme Release and Activation and the Acute‐Phase Protein Response in Patients with Acute Pancreatitis

  1995cited by this paper
• Type 1 prophospholipase A2 propeptide in acute lung injury.

  1994cited by this paper
• A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.

  1993cited by this paper
• Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis.

  1993cited by this paper
• Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis.

  1992cited by this paper
• Immunochemical detection of group I and group II phospholipases A2 in human serum.

  1992cited by this paper
• Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats.

  1991cited by this paper
• Detection of Human Pancreatic Pro-Phospholipase A2 Activation Using an Immunoassay for the Free Activation Peptide DSGISPR

  1991cited by this paper
• Released prophospholipase A2 activation peptides in the rapid early prediction of trauma outcome: a preliminary report.

  1991cited by this paper
• Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.

  1990cited by this paper
• Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems

  1990cited by this paper
• Role of phospholipase A2 in human acute pancreatitis.

  1989cited by this paper
• APACHE-II score for assessment and monitoring of acute pancreatitis.

  1989cited by this paper
• Immunoreactive pancreatic phospholipase A2 and catalytically active phospholipases A2 in serum from patients with acute pancreatitis.

  1988cited by this paper
• Development of radioimmunoassays for free tetra-L-aspartyl-L-lysine trypsinogen activation peptides (TAP).

  1988cited by this paper
• The use of relative operating characteristic (ROC) curves in test performance evaluation.

  1986cited by this paper
• Activation of pancreatic zymogens

  1986cited by this paper
• Prognostic signs and the role of operative management in acute pancreatitis.

  1974cited by this paper

• Pancreatitis Unveiled: Linking Pathogenesis, Organ Failure, and Emerging Predictive Biomarkers

  2025cites this paper
• Protease-Related Predictors of Acute Pancreatitis Severity: A Systematic Review of the Literature

  2016influential citation
• Prognostic markers in acute pancreatitis

  2014cites this paper
• Organ dysfunction and failure in critical illness: Role of mesenteric lymph and lymphatics

  2014cites this paper
• Carboxypeptidase-B from Bubalus bubalis pancreas: purification, properties and MALDI-TOF monitored activation of proinsulin.

  2013cites this paper
• The Performance of Organ Dysfunction Scores for the Early Prediction and Management of Severity in Acute Pancreatitis: An Exploratory Phase Diagnostic Study

  2010cites this paper
• Acute pancreatitis - severity classification, complications and outcome

  2010influential citation
• Protection of Salvia miltiorrhizae to the Spleen and Thymus of Rats with Severe Acute Pancreatitis or Obstructive Jaundice

  2009cites this paper
• Protective Effect of Resveratrol in Severe Acute Pancreatitis-Induced Brain Injury

  2009cites this paper
• Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis.

  2007cites this paper
• Experimental study of therapeutic efficacy of Baicalin in rats with severe acute pancreatitis.

  2007cites this paper
• Clinical Value of Severity Markers in Acute Pancreatitis

  2005cites this paper
• Laboratory Markers of Severe Acute Pancreatitis

  2005cites this paper
• Severe Acute Pancreatitis: Case-Oriented Discussion of Interdisciplinary Management

  2005cites this paper
• The N-terminal alpha-helix of pancreatic phospholipase A2 determines productive-mode orientation of the enzyme at the membrane surface.

  2004cites this paper
• Acute pancreatitis and organ failure: Pathophysiology, natural history, and management strategies

  2004cites this paper
• Beneficial effect of iloprost on the course of acute taurocholate pancreatitis in rats and its limitation by antecedent acute ethanol intake.

  2004cites this paper